Recombinant multi-species DPP8/DPP-8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DPP8/DPP-8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the peptidase S9B family, a small family of dipeptidyl peptidases that are able to cleave peptide substrates at a prolyl bond. The encoded protein shares similarity with dipeptidyl peptidase IV in that it is ubiquitously expressed, and hydrolyzes the same substrates. These similarities suggest that, like dipeptidyl peptidase IV, this protein may play a role in T-cell activation and immune function. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
The Alternative Names of target: DPP8, DPP-8,Dipeptidyl peptidase 8,DP8,Dipeptidyl peptidase IV-related protein 1 (DPRP-1), Dipeptidyl peptidase VIII (DPP VIII), Prolyl dipeptidase DPP8,DP8,DPRP1,DPRP-1,MST097,MSTP097,MSTP135,MSTP141
Go
to DPP8/DPP-8 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0070-Ab-1/ GM-Tg-hg-IP0070-Ab-2 | Human DPP8/DPP-8 protein | Human |
GM-Tg-rg-IP0070-Ab-1/ GM-Tg-rg-IP0070-Ab-2 | Rat DPP8/DPP-8 protein | Rat |
GM-Tg-mg-IP0070-Ab-1/ GM-Tg-mg-IP0070-Ab-2 | Mouse DPP8/DPP-8 protein | Mouse |
GM-Tg-cynog-IP0070-Ab-1/ GM-Tg-cynog-IP0070-Ab-2 | Cynomolgus/Rhesus macaque DPP8/DPP-8 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0070-Ab-1/ GM-Tg-felg-IP0070-Ab-2 | Feline DPP8/DPP-8 protein | Feline |
GM-Tg-cang-IP0070-Ab-1/ GM-Tg-cang-IP0070-Ab-2 | Canine DPP8/DPP-8 protein | Canine |
GM-Tg-bovg-IP0070-Ab-1/ GM-Tg-bovg-IP0070-Ab-2 | Bovine DPP8/DPP-8 protein | Bovine |
GM-Tg-equg-IP0070-Ab-1/ GM-Tg-equg-IP0070-Ab-2 | Equine DPP8/DPP-8 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP0070-Ab-1/ GM-Tg-hg-IP0070-Ab-2;
GM-Tg-rg-IP0070-Ab-1/ GM-Tg-rg-IP0070-Ab-2;
GM-Tg-mg-IP0070-Ab-1/ GM-Tg-mg-IP0070-Ab-2; GM-Tg-cynog-IP0070-Ab-1/ GM-Tg-cynog-IP0070-Ab-2; GM-Tg-felg-IP0070-Ab-1/ GM-Tg-felg-IP0070-Ab-2; GM-Tg-cang-IP0070-Ab-1/ GM-Tg-cang-IP0070-Ab-2; GM-Tg-bovg-IP0070-Ab-1/ GM-Tg-bovg-IP0070-Ab-2; GM-Tg-equg-IP0070-Ab-1/ GM-Tg-equg-IP0070-Ab-2 |
Products Name | DPP8/DPP-8 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | DPP8/DPP-8 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DPP8/DPP-8 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.